Prognostic Value of Each Codon-specific KRAS Mutation in Colorectal Cancer

NCT05657210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2203

Last updated 2022-12-20

No results posted yet for this study

Summary

This retrospective study reviewed 3,144 patients who underwent surgery for colorectal cancer. This study was designed to comprehend the clinicopathological characteristics associated with individual codon-specific KRAS mutations in colorectal cancer.

Conditions

Interventions

GENETIC

Mutation

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05657210 on ClinicalTrials.gov